Hannah M. Martin

Statistics

Publications

Citations

969

H-Index

Active since

2000

Affiliations

GlaxoSmithKline (United States)(Current)

Medical Research Council

GlaxoSmithKline (United Kingdom)

NIHR Bristol Biomedical Research Centre

Predictive Science (United States)

Hannah M. Martin is an author at GlaxoSmithKline (United States) specializing in life sciences, causal effects of genetic variants, and precision medicine.

ORCID

Publications per year

2000–2020

Publications

Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases

Jie Zheng, Valeriia Haberland, Denis Baird et al. · Nature Genetics · 2020 · 819 citations · Full text

Life Sciences, Biostatistics, Genetics +13

Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases

Jie Zheng, Valeriia Haberland, Denis Baird et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2019 · 106 citations · Full text

Life Sciences, Biostatistics, Genetics +13

Xanthine oxidoreductase is present in bile ducts of normal and cirrhotic liver

Hannah M. Martin, Kevin P. Moore, Eugène Bosmans et al. · Free Radical Biology and Medicine · 2004 · 26 citations

Medicine, Biochemistry, Pathology +12

The inhibition of flavoproteins by phenoxaiodonium, a new iodonium analogue

Paul Moulton, Hannah M. Martin, Adele Ainger et al. · European Journal of Pharmacology · 2000 · 18 citations

Life Sciences, Biochemistry, Chemistry +3

1–4 of 4